Introduction: Because primary hepatic neuroendocrine carcinoma (PHNEC) is extremely rare, a standard regimen has not yet been established. However, the combination of etoposide and cisplatin (EP) has been widely used to treat PHNEC.
Aim(s): We report two cases of PHNEC treated with EP and compare the efficacy of the EP regimen for PHNEC and pancreatic NEC (pNEC).
Materials and methods: We retrospectively analyzed the medical records of patients diagnosed with PHNEC and pNEC during January 2007–November 2012.
Conference: 10th Annual ENETS Conference 2013 (2013)
Category: Medical treatment - Chemotherapy
Presenting Author: Dr. Shoichi Nakazuru
, Iwasaki R
, Tamura T
, Iwasaki T
, Hasegawa H
, Sakakibara Y
, Yoshio T
, Toyama T
, Ishida H
, Kodama Y
, Mita E
To read results and conclusion, please login ...
Further abstracts you may be interested in